COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT, PREVENTION, OR MANAGEMENT OF HYPERPROLIFERATIVE DISORDER
Disclosed herein are compounds, pharmaceutical compositions, and methods for treating, preventing or managing diseases and conditions including hyperproliferative disorders such as cancer in humans and other mammals. Compounds disclosed herein are PTEFb inhibitor prodrugs, conjugated to an integrin binding moiety via cleavable linkers and/or functional spacers..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 13. Apr. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LERCHEN HANS-GEORG [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-04-13, Last update posted on www.tib.eu: 2023-09-21, Last updated: 2023-09-29 |
|---|
| Patentnummer: |
WO2023057812 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA002020696 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA002020696 | ||
| 003 | DE-627 | ||
| 005 | 20240327214341.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA002020696 | ||
| 035 | |a (EPA)WO2023057812 | ||
| 035 | |a (EPA)84329676 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LERCHEN HANS-GEORG |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT, PREVENTION, OR MANAGEMENT OF HYPERPROLIFERATIVE DISORDER |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-04-13, Last update posted on www.tib.eu: 2023-09-21, Last updated: 2023-09-29 | ||
| 520 | |a Disclosed herein are compounds, pharmaceutical compositions, and methods for treating, preventing or managing diseases and conditions including hyperproliferative disorders such as cancer in humans and other mammals. Compounds disclosed herein are PTEFb inhibitor prodrugs, conjugated to an integrin binding moiety via cleavable linkers and/or functional spacers. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a STELTE-LUDWIG BEATRIX |4 aut | |
| 700 | 0 | |a WIEDMANN MAREIKE |4 aut | |
| 700 | 0 | |a LERCHEN ANDREAS |4 aut | |
| 700 | 0 | |a REBSTOCK ANNE-SOPHIE |4 aut | |
| 700 | 0 | |a KOEBBERLING JOHANNES |4 aut | |
| 700 | 0 | |a WONG HARVEY |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 13. Apr. |
| 773 | 1 | 8 | |g year:2023 |g day:13 |g month:04 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/84329676/publication/WO2023057812A1?q=WO2023057812 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 13 |c 04 | ||